These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 28938667)
1. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis. Zheng C; Liu X; Chen L; Xu Z; Shao J Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667 [TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis. Liu J; Wei Y; Wang T; Zhang Z; Huang H; Wang C; Li H; Jia Q; Wu H; Zou T Int J Biol Markers; 2020 Dec; 35(4):3-11. PubMed ID: 33208027 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of long non coding RNAs in cervical cancer: A meta-analysis. Cui X; Jing X; Wu X Oncotarget; 2017 Sep; 8(37):62470-62477. PubMed ID: 28977961 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis. Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma. Qu Z; Yuan CH; Yin CQ; Guan Q; Chen H; Wang FB Onco Targets Ther; 2016; 9():5143-52. PubMed ID: 27574455 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis. Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320 [TBL] [Abstract][Full Text] [Related]
7. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis. Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis. Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of microvessel density in hepatocellular carcinoma patients: a meta-analysis. Li Y; Ma X; Zhang J; Liu X; Liu L Int J Biol Markers; 2014 Sep; 29(3):e279-87. PubMed ID: 24803279 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis. Mardani M; Rashedi S; Keykhaei M; Farrokhpour H; Azadnajafabad S; Tavolinejad H; Rezaei N Pathol Res Pract; 2022 Jan; 229():153726. PubMed ID: 34942515 [TBL] [Abstract][Full Text] [Related]
11. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis. Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868 [TBL] [Abstract][Full Text] [Related]
12. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients. Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis. Serghiou S; Kyriakopoulou A; Ioannidis JP Mol Cancer; 2016 Jun; 15(1):50. PubMed ID: 27352941 [TBL] [Abstract][Full Text] [Related]
14. Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis. Chen D; Wang H; Zhang M; Jiang S; Zhou C; Fang B; Chen P J Bone Oncol; 2018 Nov; 13():76-90. PubMed ID: 30591861 [TBL] [Abstract][Full Text] [Related]
15. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis. Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis. Luo P; Liu XF; Wang YC; Li ND; Liao SJ; Yu MX; Liang CZ; Tu JC Oncotarget; 2017 Apr; 8(14):23927-23936. PubMed ID: 28118613 [TBL] [Abstract][Full Text] [Related]
17. Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis. Chi S; Shen L; Hua T; Liu S; Zhuang G; Wang X; Zhou X; Wang G; Wang H Oncotarget; 2017 Oct; 8(45):79061-79072. PubMed ID: 29108287 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic and prognostic value of the miR-17-92 cluster in hepatocellular carcinoma: A meta-analysis. Lu F; Zhao X; Zhang Z; Xiong M; Wang Y; Sun Y; He B; Zhu J Front Genet; 2022; 13():927079. PubMed ID: 36118845 [TBL] [Abstract][Full Text] [Related]
19. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis. Yang Y; Wang S; Li T Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis. Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]